<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; Enigma Diagnostics Limited</title>
	<atom:link href="http://pr.gaeatimes.com/t/enigma-diagnostics-limited/feed/" rel="self" type="application/rss+xml" />
	<link>http://pr.gaeatimes.com</link>
	<description></description>
	<pubDate>Wed, 10 Aug 2011 05:00:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Enigma Diagnostics and GSK Announce Collaboration on Assay Development and Commercialization of Enigma&#8217;s ML Platform</title>
		<link>http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/</link>
		<comments>http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/#comments</comments>
		<pubDate>Wed, 10 Aug 2011 05:00:00 +0000</pubDate>
		<dc:creator>Enigma Diagnostics Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[August 10]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[London And Oxford]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/</guid>
		<description><![CDATA[LONDON and OXFORD, England, August 10, 2011  -

Enigma Diagnostics Limited (Enigma) and GlaxoSmithKline (GSK) today announced that they have signed agreements for the supply and commercialization on an exclusive basis of the Enigma® ML system in Europe and other designated key countries, including India, Brazil and Russia. The agreements include development by Enigma of ... <a href="http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/" title="Enigma Diagnostics and GSK Announce Collaboration on Assay Development and Commercialization of Enigma&#8217;s ML Platform">Read more >></a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enigma Announces Successful Completion of EU Framework 7 &#34;RANGER&#34; Project</title>
		<link>http://pr.gaeatimes.com/enigma-announces-successful-completion-of-eu-framework-7-ranger-project-48022/</link>
		<comments>http://pr.gaeatimes.com/enigma-announces-successful-completion-of-eu-framework-7-ranger-project-48022/#comments</comments>
		<pubDate>Mon, 18 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Enigma Diagnostics Limited</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[July 18]]></category>

		<category><![CDATA[Oxford]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/enigma-announces-successful-completion-of-eu-framework-7-ranger-project-48022/</guid>
		<description><![CDATA[OXFORD, England, July 18, 2011  -

In October 2007, Enigma Diagnostics (Porton Down, UK &#38; San
Diego, USA) announced the award of a euro 3 Million grant by the
European Commission Framework 7 programme. This EU Commission award
was won in a competitive process and the grant was to support
development of a rapid, fully automated molecular diagnostic system
for ... Original source on Gaea Times at  : <a href="http://pr.gaeatimes.com/enigma-announces-successful-completion-of-eu-framework-7-ranger-project-48022/">Enigma Announces Successful Completion of EU Framework 7 &quot;RANGER&quot; Project</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-announces-successful-completion-of-eu-framework-7-ranger-project-48022/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enigma Announces the Start of US Clinical Trials for Its Influenza A/B Detection Assay</title>
		<link>http://pr.gaeatimes.com/enigma-announces-the-start-of-us-clinical-trials-for-its-influenza-ab-detection-assay-43851/</link>
		<comments>http://pr.gaeatimes.com/enigma-announces-the-start-of-us-clinical-trials-for-its-influenza-ab-detection-assay-43851/#comments</comments>
		<pubDate>Mon, 11 Apr 2011 05:00:00 +0000</pubDate>
		<dc:creator>Enigma Diagnostics Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[April 11]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[England And San Diego]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[Milton Park]]></category>

		<category><![CDATA[Oxford]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/enigma-announces-the-start-of-us-clinical-trials-for-its-influenza-ab-detection-assay-43851/</guid>
		<description><![CDATA[MILTON PARK, OXFORD, England and SAN DIEGO, April 11, 2011  - Enigma Diagnostics announced today that it has commenced clinical trials
for its intended point of care Enigma(R) ML Influenza A/B detection assay.
Enigma will submit its application to the U.S. Food and Drug Administration
(FDA) for approval of the assay in 2012.

    The .... Source &nbsp;: <a href="http://pr.gaeatimes.com/enigma-announces-the-start-of-us-clinical-trials-for-its-influenza-ab-detection-assay-43851/" title="Enigma Announces the Start of US Clinical Trials for Its Influenza A/B Detection Assay">Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-announces-the-start-of-us-clinical-trials-for-its-influenza-ab-detection-assay-43851/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Tecan and Enigma Diagnostics Sign Licence and Collaboration Agreement</title>
		<link>http://pr.gaeatimes.com/tecan-and-enigma-diagnostics-sign-licence-and-collaboration-agreement-39878/</link>
		<comments>http://pr.gaeatimes.com/tecan-and-enigma-diagnostics-sign-licence-and-collaboration-agreement-39878/#comments</comments>
		<pubDate>Tue, 11 Jan 2011 05:00:00 +0000</pubDate>
		<dc:creator>Enigma Diagnostics Limited</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Licensing / Marketing Agreements]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[January 11]]></category>

		<category><![CDATA[Mannedorf]]></category>

		<category><![CDATA[Middle East]]></category>

		<category><![CDATA[Switzerland]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/tecan-and-enigma-diagnostics-sign-licence-and-collaboration-agreement-39878/</guid>
		<description><![CDATA[MANNEDORF, Switzerland, January 11, 2011  - The Tecan Group (SIX Swiss Exchange: TECN), a leading global provider of
laboratory instruments and solutions, and Enigma Diagnostics Limited, the
decentralised and point-of-care molecular diagnostics company, announced
today the signing of a licence and collaboration agreement. The licence
provides Tecan with access to specific Enigma intellectual property that is
used in Enigma&#39;s .... Original article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/tecan-and-enigma-diagnostics-sign-licence-and-collaboration-agreement-39878/">Tecan and Enigma Diagnostics Sign Licence and Collaboration Agreement</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/tecan-and-enigma-diagnostics-sign-licence-and-collaboration-agreement-39878/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enigma Diagnostics&apos; Patents Maintained by UK Intellectual Property Office</title>
		<link>http://pr.gaeatimes.com/enigma-diagnostics-patents-maintained-by-uk-intellectual-property-office-36722/</link>
		<comments>http://pr.gaeatimes.com/enigma-diagnostics-patents-maintained-by-uk-intellectual-property-office-36722/#comments</comments>
		<pubDate>Mon, 18 Oct 2010 05:00:00 +0000</pubDate>
		<dc:creator>Enigma Diagnostics Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Patent Law]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[France]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[October 18]]></category>

		<category><![CDATA[Oxford]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/enigma-diagnostics-patents-maintained-by-uk-intellectual-property-office-36722/</guid>
		<description><![CDATA[OXFORD, England, October 18, 2010  - Enigma Diagnostics Limited, the decentralised and point-of-care molecular
diagnostics company, announced that the UK Intellectual Property Office (IPO)
has rejected a revocation action brought by Biogene against three patents
licensed exclusively to Enigma by the Defence Science and Technology
Laboratory (Dstl), part of the UK Ministry of Defence. The patents cover
electrically conducting .... Source &nbsp;: <a href="http://pr.gaeatimes.com/enigma-diagnostics-patents-maintained-by-uk-intellectual-property-office-36722/" title="Enigma Diagnostics&apos; Patents Maintained by UK Intellectual Property Office">Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-diagnostics-patents-maintained-by-uk-intellectual-property-office-36722/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enigma Diagnostics Showcases the Enigma ML as a Service Provider at InnovHealth Summit 2010 in Abu Dhabi</title>
		<link>http://pr.gaeatimes.com/enigma-diagnostics-showcases-the-enigma-ml-as-a-service-provider-at-innovhealth-summit-2010-in-abu-dhabi-16443/</link>
		<comments>http://pr.gaeatimes.com/enigma-diagnostics-showcases-the-enigma-ml-as-a-service-provider-at-innovhealth-summit-2010-in-abu-dhabi-16443/#comments</comments>
		<pubDate>Thu, 22 Apr 2010 05:00:00 +0000</pubDate>
		<dc:creator>Enigma Diagnostics Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[April 22]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[England And San Diego]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[Europe]]></category>

		<category><![CDATA[Oxford]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/enigma-diagnostics-showcases-the-enigma-ml-as-a-service-provider-at-innovhealth-summit-2010-in-abu-dhabi-16443/</guid>
		<description><![CDATA[OXFORD, England and SAN DIEGO, April 22, 2010  - Enigma Diagnostics Limited, the decentralised and point-of-care molecular
diagnostics company, announced today that it will be a product provider at
the InnovHealth - Middle East Healthcare Innovations Summit in Abu Dhabi on
25 and 26 April 2010 and will be presenting the Enigma (&#34;Mini Laboratory&#34;)
instrument system.

   .... Source article &nbsp;: <a href="http://pr.gaeatimes.com/enigma-diagnostics-showcases-the-enigma-ml-as-a-service-provider-at-innovhealth-summit-2010-in-abu-dhabi-16443/">Enigma Diagnostics Showcases the Enigma ML as a Service Provider at InnovHealth Summit 2010 in Abu Dhabi</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-diagnostics-showcases-the-enigma-ml-as-a-service-provider-at-innovhealth-summit-2010-in-abu-dhabi-16443/feed/</wfw:commentRss>
		</item>
		<item>
		<title>US Patent Covering Amplification Consumables Granted to Enigma Diagnostics Limited</title>
		<link>http://pr.gaeatimes.com/us-patent-covering-amplification-consumables-granted-to-enigma-diagnostics-limited-16189/</link>
		<comments>http://pr.gaeatimes.com/us-patent-covering-amplification-consumables-granted-to-enigma-diagnostics-limited-16189/#comments</comments>
		<pubDate>Mon, 19 Apr 2010 05:00:00 +0000</pubDate>
		<dc:creator>Enigma Diagnostics Limited</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[April 19]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[England And San Diego]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[Europe]]></category>

		<category><![CDATA[Oxford]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/us-patent-covering-amplification-consumables-granted-to-enigma-diagnostics-limited-16189/</guid>
		<description><![CDATA[OXFORD, England and SAN DIEGO, April 19, 2010  - Enigma Diagnostics Limited, the decentralised and point-of-care molecular
diagnostics company, announced today that the U.S. Patent and Trademark
Office has granted U.S. Patent No. 7,659,096 with claims that cover the use
of amplification consumables in several current real-time and end point PCR
instruments. The consumables incorporate a thermally conducting ... Read more <a href="http://pr.gaeatimes.com/us-patent-covering-amplification-consumables-granted-to-enigma-diagnostics-limited-16189/" title="US Patent Covering Amplification Consumables Granted to Enigma Diagnostics Limited">>>></a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/us-patent-covering-amplification-consumables-granted-to-enigma-diagnostics-limited-16189/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enigma Diagnostics Announces New San Diego Office and Appointment of Joel Centeno, VP Regulatory &amp; Quality</title>
		<link>http://pr.gaeatimes.com/enigma-diagnostics-announces-new-san-diego-office-and-appointment-of-joel-centeno-vp-regulatory-quality-14090/</link>
		<comments>http://pr.gaeatimes.com/enigma-diagnostics-announces-new-san-diego-office-and-appointment-of-joel-centeno-vp-regulatory-quality-14090/#comments</comments>
		<pubDate>Thu, 04 Mar 2010 05:00:00 +0000</pubDate>
		<dc:creator>Enigma Diagnostics Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Corporate Expansion]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Personnel Announcements]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[England And San Diego]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[Europe]]></category>

		<category><![CDATA[March 4]]></category>

		<category><![CDATA[Oxford]]></category>

		<category><![CDATA[Russia]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/enigma-diagnostics-announces-new-san-diego-office-and-appointment-of-joel-centeno-vp-regulatory-quality-14090/</guid>
		<description><![CDATA[OXFORD, England and SAN DIEGO, March 4, 2010  - Enigma Diagnostics Limited, the decentralised and point-of-care molecular
diagnostics company, announced today the opening of its new Regional HQ
office in San Diego, CA and the appointment of Joel Centeno as VP Regulatory
&#38; Quality.

    The new 17,000sq ft premises on Nancy Ridge Drive in .... <a href="http://pr.gaeatimes.com/enigma-diagnostics-announces-new-san-diego-office-and-appointment-of-joel-centeno-vp-regulatory-quality-14090/">Original source &nbsp;: Enigma Diagnostics Announces New San Diego Office and Appointment of Joel Centeno, VP Regulatory &amp; Quality</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-diagnostics-announces-new-san-diego-office-and-appointment-of-joel-centeno-vp-regulatory-quality-14090/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.</title>
		<link>http://pr.gaeatimes.com/enigma-diagnostics-announces-signing-of-patent-licenses-with-roche-molecular-systems-inc-4200/</link>
		<comments>http://pr.gaeatimes.com/enigma-diagnostics-announces-signing-of-patent-licenses-with-roche-molecular-systems-inc-4200/#comments</comments>
		<pubDate>Thu, 16 Jul 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Licensing / Marketing Agreements]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[60 minutes]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[Porton down]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/enigma-diagnostics-announces-signing-of-patent-licenses-with-roche-molecular-systems-inc-4200/</guid>
		<description><![CDATA[PORTON DOWN, England - 
Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS).

The licenses signed on 15 July 2009, provide Enigma full access under patents owned or licensed by RMS and its affiliates to practice HybProbe real-time PCR .... <a href="http://pr.gaeatimes.com/enigma-diagnostics-announces-signing-of-patent-licenses-with-roche-molecular-systems-inc-4200/">Original article on Gaea Times at  &nbsp;: Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-diagnostics-announces-signing-of-patent-licenses-with-roche-molecular-systems-inc-4200/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK&#8217;s Veterinary Laboratories Agency</title>
		<link>http://pr.gaeatimes.com/enigma-diagnostics-announces-successful-evaluation-of-the-enigma-fl-by-the-uks-veterinary-laboratories-agency-3689/</link>
		<comments>http://pr.gaeatimes.com/enigma-diagnostics-announces-successful-evaluation-of-the-enigma-fl-by-the-uks-veterinary-laboratories-agency-3689/#comments</comments>
		<pubDate>Tue, 30 Jun 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Consumer Products]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pet]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[Porton down]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/enigma-diagnostics-announces-successful-evaluation-of-the-enigma-fl-by-the-uks-veterinary-laboratories-agency-3689/</guid>
		<description><![CDATA[PORTON DOWN, England - 
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today successful independent testing for bovine viral diarrhoea (BVD) by the Veterinary Laboratories Agency to evaluate the performance of the Enigma FL (Field Laboratory).

BVD is considered to be one of the main threats to cattle (1), affecting the majority of ... <a href="http://pr.gaeatimes.com/enigma-diagnostics-announces-successful-evaluation-of-the-enigma-fl-by-the-uks-veterinary-laboratories-agency-3689/">Original source on Gaea Times at  : Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK&#8217;s Veterinary Laboratories Agency</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-diagnostics-announces-successful-evaluation-of-the-enigma-fl-by-the-uks-veterinary-laboratories-agency-3689/feed/</wfw:commentRss>
		</item>
		<item>
		<title>/C O R R E C T I O N &#8212; Enigma Diagnostics Limited/</title>
		<link>http://pr.gaeatimes.com/c-o-r-r-e-c-t-i-o-n-enigma-diagnostics-limited-3694/</link>
		<comments>http://pr.gaeatimes.com/c-o-r-r-e-c-t-i-o-n-enigma-diagnostics-limited-3694/#comments</comments>
		<pubDate>Tue, 30 Jun 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Consumer Products]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pet]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[Porton down]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/c-o-r-r-e-c-t-i-o-n-enigma-diagnostics-limited-3694/</guid>
		<description><![CDATA[PORTON DOWN, England - In the news release, &#8220;Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK&#8217;s Veterinary Laboratories Agency&#8221; issued on 30 Jun 2009 13:17 GMT, by Enigma Diagnostics Limited over PR Newswire, we are advised by a representative of the company that a second footnote has been added at the ... Read more : <a href="http://pr.gaeatimes.com/c-o-r-r-e-c-t-i-o-n-enigma-diagnostics-limited-3694/">/C O R R E C T I O N &#8212; Enigma Diagnostics Limited/</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/c-o-r-r-e-c-t-i-o-n-enigma-diagnostics-limited-3694/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enigma Diagnostics Announces Patent On Real-Time Monitoring of Amplification Reactions Upheld In Entirety Following Opposition From BD at European Patent Office</title>
		<link>http://pr.gaeatimes.com/enigma-diagnostics-announces-patent-on-real-time-monitoring-of-amplification-reactions-upheld-in-entirety-following-opposition-from-bd-at-european-patent-office-3188/</link>
		<comments>http://pr.gaeatimes.com/enigma-diagnostics-announces-patent-on-real-time-monitoring-of-amplification-reactions-upheld-in-entirety-following-opposition-from-bd-at-european-patent-office-3188/#comments</comments>
		<pubDate>Tue, 16 Jun 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[Porton down]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/enigma-diagnostics-announces-patent-on-real-time-monitoring-of-amplification-reactions-upheld-in-entirety-following-opposition-from-bd-at-european-patent-office-3188/</guid>
		<description><![CDATA[PORTON DOWN, England - Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today it was issued European Patent EP1044283, which covers the use of endonuclease-based reporting in PCR and other nucleic acid amplification technologies. Becton, Dickinson and Company (BD) had filed a claim in opposition to this patent which was rejected by .... <a href="http://pr.gaeatimes.com/enigma-diagnostics-announces-patent-on-real-time-monitoring-of-amplification-reactions-upheld-in-entirety-following-opposition-from-bd-at-european-patent-office-3188/">Read the original article &nbsp;: Enigma Diagnostics Announces Patent On Real-Time Monitoring of Amplification Reactions Upheld In Entirety Following Opposition From BD at European Patent Office</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-diagnostics-announces-patent-on-real-time-monitoring-of-amplification-reactions-upheld-in-entirety-following-opposition-from-bd-at-european-patent-office-3188/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

